PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2021.00192021272273-277Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or factTerry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wonghttp://e-cmh.org/upload/pdf/cmh-2021-0019.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2021.0019, http://e-cmh.org/upload/pdf/cmh-2021-0019.pdf
Alimentary Pharmacology & Therapeutics10.1111/apt.159662020525911-912Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis BMayur Gattani, Meghraj Ingle, Shamshersingh Chauhan, Saiprasad Ladhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fapt.15966, http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15966/fullpdf
Alimentary Pharmacology & Therapeutics10.1111/apt.159922020525913-914Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors’ replyHan Ah Lee, Seung Up Kimhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fapt.15992, http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15992/fullpdf
The Korean Journal of Gastroenterology10.4166/kjg.2019.74.1.66201974166Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?Nae-Yun Heohttps://synapse.koreamed.org/pdf/10.4166/kjg.2019.74.1.66, https://synapse.koreamed.org/DOIx.php?id=10.4166/kjg.2019.74.1.66, https://synapse.koreamed.org/DOIx.php?id=10.4166/kjg.2019.74.1.66
Journal of Hepatology10.1016/s0168-8278(22)00935-7202277S283-S284Comparable risk of hepatocellular carcinoma between immune-tolerant and active phase in hepatitis B e antigen-positive patientsHan Ah Lee, Seung Up Kim, Yeon Seok Seo, Chai Hong Rimhttps://api.elsevier.com/content/article/PII:S0168827822009357?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827822009357?httpAccept=text/plain
Clinical and Molecular Hepatology10.3350/cmh.2020.02162021272295-304Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis BMi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kimhttp://e-cmh.org/upload/pdf/cmh-2020-0216.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2020.0216, http://e-cmh.org/upload/pdf/cmh-2020-0216.pdf
Journal of Hepatology10.1016/s0618-8278(19)30504-32019701e266-e267THU-231-Risk of hepatocellular carcinoma in patients with immune-tolerant chronic hepatitis BGyeol Seong, Dong Hyun Sinn, Wonseok Kang, Geum-Yon Gwak, Moon Seok Choi, Kwang Cheol Koh, Seoung Woon Paik, Yong Han Paikhttps://api.elsevier.com/content/article/PII:S0618827819305043?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0618827819305043?httpAccept=text/plain
Alimentary Pharmacology & Therapeutics10.1111/j.1365-2036.2007.03382.x2007263383-391Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosisA. D. ENRIQUEZ, M. S. CAMPBELL, K. R. REDDYhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2007.03382.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2007.03382.x/fullpdf
Journal of Hepatology10.1016/s0168-8278(16)01670-62016642S162Nucleos(T)Ide Analogue Treatment for Immune Tolerant Phase of Chronic Hepatitis B Patients Prolongs Overall Survival and Reduces the Risk of Hepatocellular Carcinoma and Cirrhosis: A Real-Life StudyY. Chang, J.-H. Lee, J.Y. Nam, H. Ahn, H. Cho, Y. Cho, Y.Y. Cho, J.-J. Yoo, M. Lee, D.H. Lee, E.J. Cho, S.J. Yu, Y.J. Kim, J.-H. Yoonhttps://api.elsevier.com/content/article/PII:S0168827816016706?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827816016706?httpAccept=text/plain
Journal of Viral Hepatitis10.1111/jvh.12332_22014213-4O113: Association of the −515A>G CDC6 polymorphism with risk to develop hepatocellular carcinoma in patients with chronic hepatitis Chttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12332_2, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12332_2, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12332_2/fullpdf